Conversely, blockade of the β2-adrenergic receptor reduced the inhibitory effect of norepinephrine on IFN-γ production by stimulated CD4+ T cells and PBMCs in MS patients (Figure 2c and Figure 3c). Here, CD4 is linked to myeloid sarcoma.